Back
Summit Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
54
SMMT
Summit Therapeutics
Last Price:
$23.97
Seasonality Move:
6.57%
7 Day Trial
ALL ACCESS PASS
$
7

Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and SMMT is experiencing slight selling pressure.
Summit Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.23 | Sell |
20-day SMA: | 25.86 | Sell |
50-day SMA: | 21.95 | Buy |
200-day SMA: | 19.19 | Buy |
8-day EMA: | 25.04 | Sell |
20-day EMA: | 24.73 | Sell |
50-day EMA: | 22.97 | Buy |
200-day EMA: | 18.44 | Buy |
Summit Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.83 | Buy |
Relative Strength Index (14 RSI): | 49.42 | Sell |
Chaikin Money Flow: | -1165503 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.85 - 28.69) | Sell |
Bollinger Bands (100): | (17.57 - 24.19) | Buy |
Summit Therapeutics Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 23.96 while SMMT 8-day simple moving average is 25.23, which is a Sell signal.
-
The stock price of SMMT is 23.96 while Summit Therapeutics 20-day SMA is 25.86, which makes it a Sell.
-
Summit Therapeutics 50-day simple moving average is 21.95 while SMMT share price is 23.96, making it a Buy technically.
-
SMMT stock price is 23.96 and Summit Therapeutics 200-day simple moving average is 19.19, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
54
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a BuyThe current Summit Therapeutics [SMMT] share price is $23.96. The Score for SMMT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
17.8B
Price in USD:
23.96
Share Volume:
2.5M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
2.10
Buy
54
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 23.96 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 23.96 while SMMT 8-day exponential moving average is 25.04, which is a Sell signal.
-
The stock price of SMMT is 23.96 while Summit Therapeutics 20-day EMA is 24.73, which makes it a Sell.
-
Summit Therapeutics 50-day exponential moving average is 22.97 while SMMT share price is 23.96, making it a Buy technically.
-
SMMT stock price is 23.96 and Summit Therapeutics 200-day simple moving average is 18.44, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 0.83, suggesting Summit Therapeutics is a Buy
-
Summit Therapeutics Relative Strength Index (RSI) is 49.42, which suggest Summit Therapeutics is oversold
-
The Bollinger Bands (25) for Summit Therapeutics is (19.85 - 28.69), which suggest Summit Therapeutics is a Buy
-
The Bollinger Bands (100) for Summit Therapeutics is (17.57 - 24.19), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.